• Investor Relations
• Applications
• Clinical Library
• News
• Events
• About Medistim
• Contact
• Our products

• Search:

• You are here:
• Start
...

Presentation of first quarter results for 2011 for MediStim ASA

The presentation takes place at Thon Hotel Vika Atrium konferansesenter in Munkedamsveien 45 Friday the 29th of April. The presentation will start at 08.00. Representatives from the company will be:

Kari Eian Krogstad - CEO
Thomas Jakobsen - CFO

News:

• • Medistim received Clearance from Canada Health for VeriQ C in Canada
  • Significant endorsement boosts Medistim Inc.’s life-saving technology
  • Medistim’s VeriQ™ System Recommended by NICE for Routine Clinical Use
  • Medistim Launches a New TTFM Probe Line for Vascular Surgery
  • Medistim’s First Sale of VeriQC™ in the US
  • Results for the second quarter and first half 2011 for MediStim ASA
  • Medi – MediStim is outlicensing ear interface technology to Freebit AS
  • MediStim strengthens its commercial organization in the USA
  • Presentation of first quarter results for 2011 for MediStim ASA
  • Notice of ordinary general meeting in MediStim ASA
  • Transit Time Flow Measurement (TTFM) to assess graft patency in cardiac surgery is now recommended by the European Guidelines on Myocardial Revascularization
  • Underpriset hjerteredder (only in norwegian)
  • 1. half 2010 for MediStim ASA
  • Presentation of first half results for 2010 for MediStim ASA
  • MediStim establishes direct sales in Belgium
  • Strengthening MediStim Marketing and Sales through recruitment of new commercial leaders